welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
Cardiac Magnetic Resonance in Children With Muscular Dystrophy
study id #: NCT01081080
condition: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Limb Girdle Muscular Dystrophy
This protocol will exploit novel state of the art cardiovascular magnetic resonance techniques to examine important changes in the heart in children with muscular dystrophy. The purpose of this study is to compare cardiac magnetic resonance (CMR) with the collected cardiac outcome data obtained in protocol: PITT1109 – Cardiac Outcome Measures in Children with Muscular Dystrophy.
mechanism of action: No pharmaceutical intervention
start date: April 2010
estimated completion: October 2011
size / enrollment: 20
Participant enrolled in the CINRG study: PITT1109 - Cardiac Outcome Measures in Children with Muscular Dystrophy
• Pregnant woman (when uncertain, participants will undergo urine testing) or lactating women
• Decompensated congestive heart failure (unable to lie flat during CMR)
• Impaired renal excretory function (calculated Glomerular Filtration Rate less than 30mL/min)
• Contra-indications to Magnetic Resonance Imaging:
-Cardiac pacemaker or implantable defibrillator
-Cerebral aneurysm clip
-Metallic ocular foreign body
-Any implanted device (i.e. insulin pump, drug infusion device)
-Metal shrapnel or bullet
A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular DystrophyThis is a multicenter, double blind, pla...
Assessment of Cardiopulmonary Function in Duchenne Muscular DystrophyThis study seeks to develop and validate...
First Duchenne Drug Approved by the FDAhttps://www.youtube.com/watch?v=xQWfXKL1...
Extracellular RNAs in Urine May Work as Biomarker for Duchenne and Myotonic Dystrophy PatientsExtracellular RNAs found in urine may be...
Myocardial late gadolinium enhancement is associated with clinical presentation in Duchenne muscular dystrophy carri...Background: Duchenne muscular dystrophy...
Quantitative EMG in Duchenne Muscular DystrophyObjective: Multi-motor unit analysis (M...
Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to strengthen FDA’s expanded access programSince the 1970s, the FDA has helped to f...